AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 X4 PharmaceuticalsLa Jolla PharmaceuticalJounce TherapeuticsDyadic InternationalEiger Biopharmaceuticals
SymbolNASDAQ:XFORNASDAQ:LJPCNASDAQ:JNCENASDAQ:DYAINASDAQ:EIGR
Price Information
Current Price$8.62$4.55$5.56$6.06$12.24
52 Week RangeBuyHoldBuyBuyBuy
Beat the Market™ Rank
Overall Score1.91.52.01.31.6
Analysis Score4.53.23.33.53.4
Community Score2.72.62.72.33.0
Dividend Score0.00.00.00.00.0
Ownership Score1.01.02.00.01.0
Earnings & Valuation Score1.30.61.90.60.6
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$19.67$19.50$9.50$12.50$24.18
% Upside from Price Target128.15% upside328.57% upside70.86% upside106.27% upside97.55% upside
Trade Information
Market Cap$138.97 million$121.76 million$183.55 million$167.29 million$304.48 million
Beta0.482.522.370.451.6
Average Volume71,647978,098372,056246,430365,713
Sales & Book Value
Annual RevenueN/A$23.05 million$147.87 million$1.68 millionN/A
Price / SalesN/A5.391.2899.08N/A
CashflowN/AN/A$1.83 per shareN/AN/A
Price / CashN/AN/A3.03N/AN/A
Book Value$10.37 per share($2.21) per share$5.25 per share$1.32 per share$2.31 per share
Price / BookN/A-2.061.064.59N/A
Profitability
Net Income$-52,810,000.00$-116,510,000.00$56.82 million$-8,310,000.00$-70,250,000.00
EPS($4.63)($4.30)$1.66($0.31)($3.08)
Trailing P/E RatioN/AN/A4.52N/AN/A
Forward P/E RatioN/AN/AN/A7.77N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-355.86%46.11%-523.65%N/A
Return on Equity (ROE)-46.37%N/A28.10%-22.87%-105.31%
Return on Assets (ROA)-35.21%-65.61%21.33%-22.05%-61.19%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.23%N/A0.11%N/A0.74%
Current Ratio15.34%5.37%10.66%28.89%6.14%
Quick Ratio15.34%5.24%10.66%28.89%6.14%
Ownership Information
Institutional Ownership Percentage69.78%79.25%75.76%12.90%76.44%
Insider Ownership Percentage3.80%33.39%44.41%24.80%6.50%
Miscellaneous
Employees63169115618
Shares Outstanding16.14 million27.30 million34.05 million27.47 million25.06 million
Next Earnings Date8/4/2020 (Estimated)8/6/2020 (Estimated)8/5/2020 (Estimated)8/11/2020 (Estimated)8/13/2020 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.